Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Anasetti

Showing results (81-90 of 223) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2013
Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in miceDapeng Wang, Yu Yu, Kelley Haarberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patientsDavid H Salinger, David K Blough, Paolo Vicini, et al.
Blood|October 12, 2007
Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effectsYaming Liang, Chen Liu, Julie Y Djeu, et al.
JAMA Oncology|September 27, 2019
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell TransplantationJoseph Pidala, Michael Martens, Claudio Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
ASBMT committee report: white paper on measurement of quality outcomesRoy B Jones, Claudio Anasetti, Peggy Appel, et al.
American Journal of Hematology|June 8, 2012
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomesJanelle B Perkins, Jamie F Shapiro, Ryan N Bookout, et al.
European Journal of Immunology|May 30, 2013
c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in miceYu Yu, Dapeng Wang, Kane Kaosaard, et al.
Plos One|March 17, 2015
Tolerance associated gene expression following allogeneic hematopoietic cell transplantationJoseph Pidala, Gregory C Bloom, Steven Eschrich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomesJoseph Pidala, Jongphil Kim, Mohamed A Kharfan-Dabaja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2016
T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in MiceJianing Fu, Yongxia Wu, Hung Nguyen, et al.
Pageof 23

Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2013
Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in miceDapeng Wang, Yu Yu, Kelley Haarberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patientsDavid H Salinger, David K Blough, Paolo Vicini, et al.
Blood|October 12, 2007
Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effectsYaming Liang, Chen Liu, Julie Y Djeu, et al.
JAMA Oncology|September 27, 2019
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell TransplantationJoseph Pidala, Michael Martens, Claudio Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
ASBMT committee report: white paper on measurement of quality outcomesRoy B Jones, Claudio Anasetti, Peggy Appel, et al.
American Journal of Hematology|June 8, 2012
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomesJanelle B Perkins, Jamie F Shapiro, Ryan N Bookout, et al.
European Journal of Immunology|May 30, 2013
c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in miceYu Yu, Dapeng Wang, Kane Kaosaard, et al.
Plos One|March 17, 2015
Tolerance associated gene expression following allogeneic hematopoietic cell transplantationJoseph Pidala, Gregory C Bloom, Steven Eschrich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomesJoseph Pidala, Jongphil Kim, Mohamed A Kharfan-Dabaja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2016
T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in MiceJianing Fu, Yongxia Wu, Hung Nguyen, et al.
Pageof 23